Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.82 - $3.16 $1.42 Million - $2.47 Million
-781,247 Reduced 32.17%
1,647,243 $3.95 Million
Q3 2023

Nov 13, 2023

BUY
$3.17 - $7.91 $4.1 Million - $10.2 Million
1,294,070 Added 114.07%
2,428,490 $8.26 Million
Q2 2023

Aug 11, 2023

BUY
$7.35 - $13.21 $1.4 Million - $2.52 Million
190,760 Added 20.21%
1,134,420 $8.34 Million
Q1 2023

May 15, 2023

BUY
$7.79 - $16.29 $828,077 - $1.73 Million
106,300 Added 12.69%
943,660 $9.78 Million
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $5.33 Million - $10.4 Million
484,860 Added 137.55%
837,360 $9.89 Million
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $1.62 Million - $2.88 Million
80,440 Added 29.57%
352,500 $7.4 Million
Q2 2022

Aug 12, 2022

BUY
$27.42 - $43.63 $789,696 - $1.26 Million
28,800 Added 11.84%
272,060 $8.45 Million
Q1 2022

May 13, 2022

BUY
$36.48 - $52.22 $475,334 - $680,426
13,030 Added 5.66%
243,260 $9.99 Million
Q4 2021

Feb 11, 2022

BUY
$33.11 - $55.01 $2.62 Million - $4.35 Million
79,000 Added 52.24%
230,230 $10 Million
Q3 2021

Nov 12, 2021

BUY
$50.07 - $66.05 $7.57 Million - $9.99 Million
151,230 New
151,230 $7.57 Million
Q1 2019

May 14, 2019

SELL
$48.23 - $66.16 $1.73 Million - $2.37 Million
-35,794 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$55.63 - $73.24 $653,875 - $860,862
-11,754 Reduced 24.72%
35,794 $2.12 Million
Q3 2018

Nov 14, 2018

BUY
$52.05 - $66.51 $643,129 - $821,797
12,356 Added 35.11%
47,548 $3.13 Million
Q2 2018

Aug 13, 2018

BUY
$48.33 - $55.64 $758,056 - $872,713
15,685 Added 80.41%
35,192 $1.78 Million
Q4 2017

Feb 13, 2018

BUY
$37.77 - $47.75 $736,779 - $931,459
19,507
19,507 $906,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Hotchkis & Wiley Capital Management LLC Portfolio

Follow Hotchkis & Wiley Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hotchkis & Wiley Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hotchkis & Wiley Capital Management LLC with notifications on news.